Thyrocare Technologies Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 31, 2025
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has submitted its Annual Report for FY 2024-25 and notice for its 25th Annual General Meeting, scheduled for July 31, 2025, at 10:30 AM at its Navi Mumbai corporate office. Consolidated revenue grew 20% YoY to ₹687.35 crore, while net profit rose about 31% to ₹90.75 crore (standalone profit was ₹95.78 crore). The company also became the first national diagnostic chain in India to achieve 100% NABL accreditation across its 29 owned labs, conducted 167.9 million tests (14% YoY growth), and expanded its franchisee base to over 11,000. The Board has recommended a final dividend of ₹21 per share (210% of face value), subject to shareholder approval at the AGM. E-voting for the AGM will be open from July 28 to July 30, 2025.
This is a routine AGM and annual report filing, but it comes with strong FY25 results (revenue up 20%, profit up ~31%) and a healthy ₹21/share dividend, which is likely to be viewed positively by shareholders. The 100% NABL accreditation milestone and continued network expansion reinforce the company's quality and growth narrative.